Etidocaine (CID 37497) - BioAssay Data Summary for Compound
.
BioActivity Outcomes:
Active(3)
 
 
Inactive(6)
 
 
Unspecified(8)
 
 
Top Targets:
NAD binding 8(2)
 
 
BioAssay Types:
Literature(12)
 
 
 
 
Screening(2)
 
 
Confirmatory(2)
 
 
BioActivity Types:
IC50(2)
 
 
Potency(2)
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 17    Data Row: 17   Total Pages: 1   
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID103170019]
IC50 3.5Displacement of [3H]-BTX-B from neuronal voltage-gated sodium channel in rat cerebral cortex synaptoneurosomes [AID450269, Type: Literature]
View
2
[SID103170019]
IC50 3.5Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex [AID205267, Type: Literature]
View
3
[SID48415986]
DSSTox (FDAMDD) FDA Maximum (Recommended) Daily Dose Database [AID1195, Type: other]
View
4
[SID103170019]
Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex at 10 uM [AID205268, Type: Literature]
View
5
[SID103170019]
Lethal dose of compound evaluated by administering intraperitoneally to female CRCD mice [AID27367, Type: Literature]
View
6
[SID103170019]
Lethal dose of compound evaluated by administering intravenously to female CRCD mice [AID27368, Type: Literature]
View
7
[SID103170019]
Anesthetic activity of compound (0.125%) was evaluated by duration of sciatic nerve block [AID174466, Type: Literature]
View
8
[SID103170019]
Anesthetic activity of compound (0.25%) was evaluated by duration of sciatic nerve block [AID174596, Type: Literature]
View
9
[SID103170019]
Anesthetic activity of compound (0.5%) was evaluated by duration of sciatic nerve block [AID174598, Type: Literature]
View
10
[SID103170019]
Lipophilicity, log P of the compound [AID450273, Type: Literature]
View
11
[SID103170019]
Literature-mined public compounds from Kruhlak et al phospholipidosis modelling dataset [AID588220, Type: Literature]
View
12
[SID144206521]
qHTS of D3 Dopamine Receptor Potentiators: qHTS [AID652051, Type: screening]DRD3 gene product [Homo sapiens] [gi:89191863]
View
13
[SID144206521]
qHTS of D3 Dopamine Receptor Potentiators: qHTS [AID652051, Type: screening]DRD3 gene product [Homo sapiens] [gi:89191863]
View
14
[SID144206521]
qHTS of D3 Dopamine Receptor Potentiators: qHTS [AID652051, Type: screening]DRD3 gene product [Homo sapiens] [gi:89191863]
View
15
[SID144206521]
qHTS of D3 Dopamine Receptor Potentiators: qHTS [AID652051, Type: screening]DRD3 gene product [Homo sapiens] [gi:89191863]
View
16
[SID144206521]
qHTS of D3 Dopamine Receptor Agonist: qHTS [AID652048, Type: screening]DRD3 gene product [Homo sapiens] [gi:89191863]
View
17
[SID144206521]
qHTS of D3 Dopamine Receptor Agonist: qHTS [AID652048, Type: screening]DRD3 gene product [Homo sapiens] [gi:89191863]
View
18
[SID144206521]
qHTS of D3 Dopamine Receptor Agonist: qHTS [AID652048, Type: screening]DRD3 gene product [Homo sapiens] [gi:89191863]
View
19
[SID144206521]
qHTS of D3 Dopamine Receptor Agonist: qHTS [AID652048, Type: screening]DRD3 gene product [Homo sapiens] [gi:89191863]
View
20
[SID103170019]
Inhibition of mouse brain MAOA [AID409954, Type: Literature]Amine oxidase [flavin-containing] A [gi:341940599]
View
21
[SID144206521]
Potency qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory]TDP1 protein [Homo sapiens] [gi:79154014]
View
22
[SID144206521]
Potency qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory]TDP1 protein [Homo sapiens] [gi:79154014]
View
23
[SID144206521]
Potency qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory]TDP1 protein [Homo sapiens] [gi:79154014]
View
24
[SID144206521]
Potency qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory]TDP1 protein [Homo sapiens] [gi:79154014]
View
25
[SID144206521]
Potency qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory]TDP1 protein [Homo sapiens] [gi:79154014]
View
26
[SID144206521]
Potency qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory]TDP1 protein [Homo sapiens] [gi:79154014]
View
27
[SID103170019]
Inhibition of mouse brain MAOB [AID409956, Type: Literature]Amine oxidase [flavin-containing] B [gi:341940629]
View